MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients

Even though anti-interferon beta (IFNβ) antibodies are the main determinants of IFNβ bioactivity loss and Myxovirus-resistance protein A (MxA) is the most established marker of IFNβ biological activity in IFNβ-treated multiple sclerosis patients, their usefulness in the routine clinical practice is...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Serana, Federico, Imberti, Luisa, Amato, Maria Pia, Comi, Giancarlo, Gasperini, Claudio, Ghezzi, Angelo, Martinelli, Vittorio, Provinciali, Leandro, Rottoli, Maria Rosa, Sotgiu, Stefano, Stecchi, Sergio, Vecchio, Michele, Zaffaroni, Mauro, Cordioli, Cinzia, Capra, Ruggero
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2014
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3986392/
https://ncbi.nlm.nih.gov/pubmed/24733382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0094794
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items